MTR-16 MISMATCH REPAIR DEFECTS PREDICT CLINICAL OUTCOME OF PRIMARY AND RECURRENT MALIGNANT GLIOMAS

Lignende værker

• PATH-45. DIFFERENT TYPES OF HYPERMUTATOR PHENOTYPE OF GLIOBLASTOMA ACCORDING TO MUTATION PATTERNS OF MISMATCH REPAIR GENES
  af: Saito, Kuniaki, et al.
  Udgivet: (2019)
• GENE-61. TEMOZOLOMIDE-INDUCED MISMATCH REPAIR INSUFFICIENCY AND HYPERMETHYLATION OF MGMT PROMOTER WITH HYPERMUTATION IN MALIGNANT GLIOMAS
  af: Saito, Kuniaki, et al.
  Udgivet: (2017)
• Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status
  af: Tabei, Yusuke, et al.
  Udgivet: (2020)
• PATH-08. CHALLENGES IN OPTIMIZATION OF MGMT PROMOTER METHYLATION ASSAYS FOR DEVELOPMENT OF COMPANION DIAGNOSIS IN GLIOBLASTOMA
  af: Nagane, Motoo, et al.
  Udgivet: (2019)
• STMO-09 Recovery from speech deficit after injury to frontal aslant tract in glioma surgery
  af: Saito, Kuniaki, et al.
  Udgivet: (2020)